Mesa Laboratories, Inc. Stock price

Equities

MLAB

US59064R1095

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
107.2 USD +4.80% Intraday chart for Mesa Laboratories, Inc. +2.68% +2.37%
Sales 2024 * 213M Sales 2025 * 235M Capitalization 579M
Net income 2024 * - Net income 2025 * 2M EV / Sales 2024 * 2.72 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 2.47 x
P/E ratio 2024 *
-1,950 x
P/E ratio 2025 *
286 x
Employees 698
Yield 2024 *
0.6%
Yield 2025 *
0.6%
Free-Float 94.26%
More Fundamentals * Assessed data
Dynamic Chart
Earnings Flash (MLAB) MESA LABORATORIES Posts Q3 Revenue $53.5M MT
Earnings Flash (MLAB) MESA LABORATORIES Reports Q3 EPS $2.02 MT
Mesa Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Mesa Laboratories, Inc. Appoints Mark Capone to Its Board of Directors CI
Mesa Laboratories Maintains Quarterly Dividend at $0.16 a Share, Payable March 15 to Shareholders of Record as of Feb. 29 MT
Mesa Laboratories, Inc. Declares Regular Quarterly Dividend, Payable on March 15, 2024 CI
Evercore ISI Upgrades Mesa Laboratories to Outperform From In-Line, Raises Price Target to $125 From $100 MT
Mesa Laboratories Completes Acquisition of GKE's Chinese Sales Entity MT
Mesa Laboratories, Inc. acquired Beijing GKE Science & Technology Co. LTD for ?5 million CI
Earnings Flash (MLAB) MESA LABORATORIES Posts Q2 Revenue $53.2M MT
Earnings Flash (MLAB) MESA LABORATORIES Posts Q2 EPS $1.91 MT
Tranche Update on Mesa Laboratories, Inc.'s Equity Buyback Plan announced on November 10, 2005. CI
Mesa Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Mesa Laboratories Completes Acquisition of GKE's Sterilization Indicators Business, Testing Lab SAL MT
Mesa Laboratories, Inc. entered into a definitive agreement to acquire Beijing GKE Science & Technology Co. LTD for ?5 million. CI
More news
1 day+4.80%
1 week+2.68%
Current month-1.78%
1 month-0.45%
3 months+3.31%
6 months+0.33%
Current year+2.37%
More quotes
1 week
98.83
Extreme 98.8274
108.51
1 month
98.33
Extreme 98.33
115.75
Current year
88.65
Extreme 88.65
115.75
1 year
82.86
Extreme 82.86
187.75
3 years
82.86
Extreme 82.86
333.42
5 years
82.86
Extreme 82.86
333.42
10 years
54.60
Extreme 54.598
333.42
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 17-03-19
Chairman 71 04-09-30
Director of Finance/CFO 55 12-10-28
Members of the board TitleAgeSince
Chairman 71 04-09-30
Director/Board Member 61 Jan. 04
Director/Board Member 65 22-06-22
More insiders
Date Price Change Volume
24-03-27 107.2 +4.80% 21,490
24-03-26 102.3 +2.46% 42,616
24-03-25 99.88 -3.04% 25,382
24-03-22 103 -3.30% 23,324
24-03-21 106.5 +1.99% 60,632

Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT

More quotes
Mesa Laboratories, Inc. is a multinational manufacturer, developer, and seller of life sciences tools and critical quality control solutions. Its segments include Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. Its Clinical Genomics segment develops, manufactures, and sells throughput genetic analysis tools used by labs to perform clinical genomic testing in several therapeutic areas. Its Sterilization and Disinfection Control segment manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization and disinfection processes. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Calibration Solutions segment develops, manufactures, and sells quality control products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
107.2 USD
Average target price
127 USD
Spread / Average Target
+18.41%
Consensus
  1. Stock
  2. Equities
  3. Stock Mesa Laboratories, Inc. - Nasdaq